The Therapeutic Goods
Adminisatration has issued its
latest Medicines Safety Update
highlighting changes for three
products.
Immunosuppressant
mycophenolate mofetil has new
contraindications.
Smoking cessation therapy
varenicline (Champix) adds risks of
psychiatric symptoms and alcohol
interactions.
Multiple sclerosis drug baclofen
has a potential contamination.
Go to www.tga.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 04 Feb 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Feb 16
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.